• 5071 Citations
  • 38 Scopus h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Tanios Bekaii-Saab is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
irinotecan Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

12 Citations (Scopus)

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

Shroff, R. T., Kennedy, E. B., Bachini, M., Bekaii-Saab, T., Crane, C., Edeline, J., El-Khoueiry, A., Feng, M., Katz, M. H. G., Primrose, J., Soares, H. P., Valle, J. & Maithel, S. K., Apr 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 12, p. 1015-1027 13 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Practice Guidelines
Gallbladder Neoplasms
Cholangiocarcinoma
Randomized Controlled Trials

A Rare EGFR–SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib

Li, Y., Zhang, H. B., Chen, X., Yang, X., Ye, Y., Bekaii-Saab, T., Zheng, Y. & Zhang, Y., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Epidermal Growth Factor Receptor
Adenocarcinoma
Protein-Tyrosine Kinases
Gene Fusion

Assessment of Treatment with Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients with Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

Abou-Alfa, G. K., Shi, Q., Knox, J. J., Kaubisch, A., Niedzwiecki, D., Posey, J., Tan, B. R., Kavan, P., Goel, R., Lammers, P. E., Bekaii-Saab, T. S., Tam, V. C., Rajdev, L., Kelley, R. K., El Dika, I., Zemla, T., Potaracke, R. I., Balletti, J., El-Khoueiry, A. B., Harding, J. H. & 7 others, Suga, J. M., Schwartz, L. H., Goldberg, R. M., Bertagnolli, M. M., Meyerhardt, J., O'Reilly, E. M. & Venook, A. P., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

Doxorubicin
Hepatocellular Carcinoma
Randomized Controlled Trials
Survival
Therapeutics

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer

Sonbol, M. B., Benkhadra, R., Wang, Z., Firwana, B., Walden, D. J., Mody, K., Hubbard, J. M., Murad, M. H., Ahn, D. & Bekaii-Saab, T., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalReview article

Colorectal Neoplasms
Disease-Free Survival
Survival
irinotecan
oxaliplatin